Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAMUSCULAR, INTRAVENOUSStandard

KETAMINE HYDROCHLORIDE

KETAMINE HYDROCHLORIDE

Standard Dose
EQ 100MG BASE/10ML (EQ 10MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview KETAMINE HYDROCHLORIDE is listed in Drugs@FDA under application 219684 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient KETAMINE HYDROCHLORIDE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS - EQ 100MG BASE/10ML (EQ 10MG BASE/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-09-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview KETAMINE HYDROCHLORIDE is listed in Drugs@FDA under application 219684 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient KETAMINE HYDROCHLORIDE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS - EQ 100MG BASE/10ML (EQ 10MG BASE/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-09-17 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.